EDGAR Filing Documents for 0001104659-19-054215

Form F-1 - Registration statement for certain foreign private issuers:

SEC Accession No. 0001104659-19-054215

Filing Date

2019-10-15

Accepted

2019-10-15 17:23:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-1	tv531053_f-1.htm	F-1	511681
2	EXHIBIT 5.1	tv531053_ex5-1.htm	EX-5.1	35763
3	EXHIBIT 23.1	tv531053_ex23-1.htm	EX-23.1	3291
4	GRAPHIC	image_001.jpg	GRAPHIC	3260
	Complete submission text file	0001104659-19-054215.txt		556528

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1 | Act: 33 | File No.: 333-234219 | Film No.: 191151621
SIC: 2834 Pharmaceutical Preparations